Introduction to How To Manage P53 Mutated Cll
Exploring How To Manage P53 Mutated Cll reveals several interesting facts. This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
How To Manage P53 Mutated Cll Comprehensive Overview
Paolo Ghia, MD, Università Vita-Salute San Raffaele, Milan, Italy, comments on the importance of testing for IgHV and TP53 ... In this month's “Hot Topic,” Dr. Curt Hanson will discuss the use of laboratory-based prognostic markers in patients with Riccardo Bomben, PhD, CRO Centre of Oncological Reference of Aviano, Aviano, Italy, discusses
Florence Cymbalista, MD, Hôpital Avicenne, Bobigny, France, comments on the use of next-generation sequencing (NGS) to ...
Summary & Highlights for How To Manage P53 Mutated Cll
- In this video, Richard Rosenquist, MD, PhD, Karolinska Institute, Stockholm, Sweden, comments on the important role of TP53 in ...
- William Wierda, MD, PhD, discusses the prevalence of TP53 and deletion 17p as predictive and prognostic markers in patients ...
- William Wierda, MD, PhD; Matthew S. Davids, MD, MMSc; Adam Bagg, MD; and Nitin Jain, MD, describe the case of a 75-year-old ...
- Simon Rule, MD, PhD, professor of hematology, Plymouth University Medical Center, United Kingdom, discusses the treatment of ...
- Bijal D. Shah, MD, medical oncologist, Moffitt Cancer Center, assistant professor of oncology, University of South Florida, ...
Stay tuned for more updates related to How To Manage P53 Mutated Cll.